Benjamin Ulfenborg

Artificial intelligence (AI) is an important driving force that is rapidly transforming health care and pharmaceutical industries in several ways. The vast amount of biomedical data available today poses unique opportunities to develop a repertoire of AI-based models. Although the results from studies using AI for solving biomedical problems are encouraging, there are numerous scientific challenges associated with AI for life science applications that need to be addressed.

The Transplant Tissue Engineering (TransTissuE) is a collaboration project between the University of Skövde, VERIGRAFT and XVIVO. We develop methods and strategies for optimization of the production process of personalized tissue-engineered vascular transplants.

The aim of this project is to contribute with improved methods for analysis, integration, and visualization of biomedical big data. Recent years it has been a massive digitalization of all types of data and information in the society and the majority of all information in the world is nowadays anticipated to be digitalized. This encompasses enormous possibilities for generation of new knowledge but also puts demands on competence and tools for analysis and interpretation of big and complex data, e.g. to identify and extract patterns and information from different data sources. To meet these increasing demands of large-scale data analysis more competence, better and faster algorithms, and powerful computers are needed for execution these algorithms.

Big data has gained much interesting in recent years due to the rapid expansion of the massive amount of data that is available for solving different types of tasks within many different application domains. However, today's big data is still on a fairly low level of abstraction when it comes to complex decision support tasks, subject to e.g. high dimensionality and significant portions of uncertainty regarding which patterns to look for in the data.

The pharmaceutical industry has an urgent need for in vitro model systems with high human relevance that can be used for toxicity testing, drug development, and disease modelling. The project aims at developing a human in vitro model based on human pluripotent stem cells that can mimic important aspects of the blood-brain-barrier.

This project is one of the three subprojects within the synergy project BioMine - Data-mining for biomarker discovery, selection, and validation. In this subproject we investigate how large-scale biomolecular data can be used to identify specific biomarkers for disease modelling

This project is one of the three subprojects within the synergy project BioMine - Data-mining for biomarker discovery, selection, and validation. In this subproject we investigate how large-scale biomolecular data can be used to identify specific biomarkers for toxicity testing. The project is performed in close collaboration between the University of Skövde, AstraZeneca Gothenburg and Takara Bio Europe.

In the BioMine project (Data-mining for Biomarker Discovery, Selection, and Validation), studies are performed on how large-scale biomolecular data can be mined to enable discovery and validation of multilevel biomarkers in Life Science.

Within AlgorOmics we develop and implement algorithms for integration, visualization, and analysis of large-scale omics data, with applications in stem cell differentiation and drug development.